Martyn Hulley is a skilled professional with over 10 years of experience in the biopharmaceutical industry, currently serving as the Director of Bioprocess Development (Purification Process Sciences) at AstraZeneca. Martyn has led cross-functional teams in the successful delivery of development programs, regulatory submissions, and clinical material supply, while also overseeing purification contributions to biomolecule development. Their expertise spans a wide range of therapeutic modalities, including mAb, mRNA, AAV, and ADC, and they have demonstrated a strong focus on innovation and the adoption of novel technologies in the bioprocessing space. Martyn's previous roles include positions at Eden Biodesign, Actavis Biologics Ltd., and Allergan Biologics Ltd., complementing their academic background with a PhD from the University of Manchester.
This person is not in the org chart
This person is not in any teams
This person is not in any offices